MAPT and amyloidosis: The underlying pathophysiology of AD is complex, involving the accumulation of amyloid-beta plaques, hyperphosphorylation of tau proteins, and the disruption of neural networks (Yang Y. et al., 2022; Taylor et al., 2023; Ashrafian et al., 2021; Otero-Garcia et al., 2022).